| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.053 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |